Emergency Medicine Cardiac Research and Education Group




COMPLIMENTARY CME DINNER SYMPOSIUM - AHA 2017
Join EMCREG and Dr. Chris Granger for complimentary CME dinner symposium entitled
Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease

SUNDAY, NOVEMBER 12, 2017
Registration/Buffet Dinner at 6:30 PM
Symposium 7:00-10:00 PM

MARRIOTT HOTEL ANAHEIM
Marquis Ballroom South - Adjacent to Anaheim Convention Center

REGISTER ON-LINE or ON-SITE: REGISTER NOW ONLINE

Our expert program faculty will be discussing state-of-the-art evidence-based mangaement of stable and peripheral coronary artery disease in this interactive educational event
including an Audience Response System, Case Review, and Expert Q&A Panel.

PROGRAM CHAIRS and FACULTY:

Christopher B. Granger, MD (Chair) - Duke University Medical Center
W. Brian Gibler, MD (Co-Chair) - President, EMCREG-International, University of Cincinnai

FACTOR Xa MECHANISM OF ACTION - IMPACT ON THE CLOTTING CASCADE, TISSUE FACTOR-INITIATED CLOTTING, INFLAMMATION, AND PLATELET ACTIVATION
Richard C. Becker, MD
University of Cincinnati College of Medicine, Cincinnati, OH

DECREASING MAJOR ADVERSE CLINICAL EVENTS FOR PATIENTS WITH CORONARY ARTERY DISEASE AND PERIPHERAL ARTERY DISEASE: THE COMPASS TRIAL
Deepak L. Bhatt, MD, MPH
Duke University Medical Center, Durham, NC

IMPROVING THE TREATMENT OF PERIPHERAL ARTERY DISEASE: PROVIDING INDIVIDUALIZED, INNOVATIVE, AND EFFICIENT CARE
Manesh R. Patel, MD
Duke University, Durham, NC

CLINICAL AND ECONOMIC VALUE OF RIVAROXABAN IN CORONARY ARTERY DISEASE
Christopher B. Granger, MD
Duke University Medical Center, Durham, NC

Impact of High Sensitivity Troponin on the Evaluation and Treatment of Patients with Acute Coronary Syndrome

This monograph dicusses the use of high sensitivity troponin assays in patients presenting to the hospital with ACS from multiple perspectives including Emergency Medicine, Cardiology, Hospital Medicine, Laboratory Medicine, and Emergency Nursing. High sensitivity assays for troponin have been available for clinical use in Europe for the past decade and proved to be critical for the early diagnosis of acute myocardial necrosis in patients presenting to the emergency department (ED) with possible ACS and defining treatment for these patients which includes anti-platelet and anti-coagulant agents, as well as cardiologist intervention. In March 2017, high sensitivity cardiac troponin T was approved by the FDA for routine clinical use in the United States. Clearly many clinicians and laboratorians in the US have not had experience with high sensitivity troponin assays which has identified an important educational area for emphasis. This information on high sensitivity troponin becomes extremely important to emergency physicians, cardiologists, hospitalists, laboratorians, physician assistants, nurse practitioners, and emergency nurses as they routinely care for these often critically-ill patients.
  1. Describe the use of high-sensitivity troponin assays with the integration of the multi-disciplinary team
  2. Describe the evidence for high-sensitivity troponinassays in ACS
  3. Describe the effectiveness of these assays when combined diagnostics algorithms like the HEART score
  4. Discuss the importance of high-sensitivity troponin for the hospitalist as care is transitioned from the ED to the in-patient setting
  5. Discuss the laboratory medicine perspective and the capabilities of the high sensitivity troponin assays
  6. Discuss the critical role of emergency nurses, advanced practice nurses, and physician assistants in treating these patients with this exciting new technology
Impact of High Sensitivity Troponin on the Evaluation and Treatment of Patients with Acute Coronary Syndrome

Optimal Therapy For ACS - Guideline-Based Treatments in the Emergency Department

In this EMCREG-International Monograph, you will find a variety of cardiovascular articles which will hopefully be helpful to you in your practice of Emergency Medicine and Acute Care Medicine. These manuscripts are based on the 2015 EMCREG-International Satellite Symposium which was held on October 25, 2015, during the 2015 ACEP Scientific Assembly in Boston, Massachusetts. The symposium and this Monograph entitled Optimal Therapy for Acute Coronary Syndromes: Using Guideline-Based Treatments in the Emergency Setting explore multiple Acute Coronary Syndrome (ACS) topics which are extremely important to emergency physicians, hospitalists, and other acute care providers such as physician assistants and nurse practitioners as they care for these often critically-ill patients.
  1. Identification of Patients with ACS in the ED at High Risk of Adverse Outcomes
  2. 2013 ACCF/AHA Guidelines for STEMI Patients
  3. 2014 ACCF/AHA Guideline for Treating Non-ST-Elevation ACS (NSTE ACS)
  4. Challenges in Optimizing Antiplatelet Therapy for STEMI and NSTE ACS
  5. Thromboelastography (TEG) – Understanding the Patient’s Ability to Clot Blood
  6. Optimizing Collaboration Between Emergency Physicians, Hospitalists, and Cardiologists for Treatment of ACS
Impact of High Sensitivity Troponin on the Evaluation and Treatment of Patients with Acute Coronary Syndrome

Prescribing information for Direct Thrombin Inhibitor:
COAGULATION CATASTROPHIES: TAKING CARE OF THE MOST DIFFICULT CASES IN EM
Join faculty experts, W. Brian Gibler, MD; James W. Hoekstra, MD; Charles Pollack, MD; E. Magnus Ohman, MD; Phillip Levy, MD; Jordon Bonomo, MD and Opeolu Adeoyeo, MD, as they review recent advances in cardiac biomarker diagnostics including high-sensitivity troponin assays and CT coronary angiography, novel anticoagulant therapy, advances in antiplatelet therapy which have been incorporated into the latest ACCF/AHA guidelines, the interventional cardiologists perspective, and novel diagnostics for determining a patient’s clotting status by thromboelastography.

View the monograph.
CARING FOR CRITICALLY ILL AND INJURED PATIENTS IN THE EMERGENCY DEPARTMENT
CARING FOR CRITICALLY ILL AND INJURED PATIENTS IN THE EMERGENCY DEPARTMENT
Join faculty experts as they review Emergency Physicians and Hospitalists care daily for patients who are critically ill and injured. The management of these patients is often complex and requires detailed diagnostic and therapeutic information, as well as a thorough understanding of disease pathophysiology. In this EMCREG-International Monograph, multiple critical care topics including critical respiratory illness/ventilator management, current therapy for septic shock, treatment of significant deep venous thrombosis and pulmonary embolism, management of atrial fibrillation, novel Factor Xa inhibitors and other antagonists to the clotting cascade, post-cardiac arrest resuscitation beyond hypothermia, and the use of thromboelastography to evaluate the patient’s ability to clot blood. .

View the work in PDF Format.

View the monograph archive . . .


Minimizing Transfer Time to an ST Segment Elevation Myocardial Infarction-Receiving Center: A Modified Delphi Consensus
Mumma, Bryn E.; Williamson, Conrad; Khare, Rahul K.; Mackey, Kevin E.; Diercks, Deborah B.
Crit Pathw Cardiol. 2014;13(1):20-24

A Pilot Study of Implantable Cardiac Device Interrogation by Emergency Department Personnel
Neuenschwander, James F.; Hiestand, Brian C.; Peacock, W. Frank; Billings, John M.; Sondrup, Cole; Hummel, John D.; Abraham, William T.
Crit Pathw Cardiol. 2014;13(1):6-8

Lessons in Flying: Crew Resource Management as a Quality Improvement Method for Acute Coronary Syndromes Care
Levy, Phillip D.; Dancy, JaNeen N.; Stowell, Stephanie A.; Hoekstra, James W.; Arthur, Crystal L.; Wilson, Charles H.; Bednar, John M.; Dorman, Todd; Hiestand, Brian
Crit Pathw Cardiol. 2014;13(1):36-42

Variable Impact of State Legislative Advocacy on Registry Participation and Regional Systems of Care Implementation: A Policy Statement From the American Heart Association
Rokos IC, Schwamm LH, Konig M, Malcarney MB, Horton KB, Ranous J, Ellrodt AG, Farmer SA, Frankel MR, Ferguson TB, Goff DC Jr, Hiratzka L, Jacobs AK; American Heart Association Advocacy Coordinating Committee
Circulation. 2013 Oct 15;128(16):1799-809. doi: 10.1161/CIR.0b013e3182a8fc62. Epub 2013 Sep 16.

Identifying patients for early discharge: Performance of decision rules among patients with acute chest pain
Mahler SA, Miller CD, Hollander JE, Nagurney JT, Birkhahn R, Singer AJ, Shapiro NI, Glynn T, Nowak R, Safdar B, Peberdy M, Counselman FL, Chandra A, Kosowsky J, Neuenschwander J, Schrock JW, Plantholt S, Diercks DB, Peacock WF
Int J Cardiol. 2013 Sep 30;168(2):795-802. doi: 10.1016/j.ijcard.2012.10.010. Epub 2012 Oct 30.

Nitrates for acute heart failure syndromes
Wakai A, McCabe A, Kidney R, Brooks SC, Seupaul RA, Diercks DB, Salter N, Fermann GJ, Pospisil C.
Cochrane Database Syst Rev. 2013 Aug 6;8:CD005151. doi: 10.1002/14651858.CD005151.pub2

How Low Can We Go? The High-Sensitivity Cardiac Troponin Debate
Storrow AB, Lardaro TA, Alexander PT, Apple FS
Ann Emerg Med. 2013 Dec;62(6):580-3. doi: 10.1016/j.annemergmed.2013.03.021. Epub 2013 Apr 6

Emergency Department Bypass for ST-Segment–Elevation Myocardial Infarction Patients Identified With a Prehospital Electrocardiogram: A Report From the American Heart Association Mission: Lifeline Program
Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT
Circulation. 2013 Jul 23;128(4):352-9. doi: 10.1161/CIRCULATIONAHA.113.002339. Epub 2013 Jun 20

Nitrates for acute heart failure syndromes
Wakai A, McCabe A, Kidney R, Brooks SC, Seupaul RA, Diercks DB, Salter N, Fermann GJ, Pospisil C
Cochrane Database Syst Rev. 2013; 8: CD005151

Impact of Society of Cardiovascular Patient Care Accreditation on Quality: An Action Registry(R)-Get With the Guidelines Analysis
Peacock WF, Kontos MC, Amsterdam E, Cannon CP, Diercks D, Garvey L, Graff L 4th, Holmes D, Holmes KS, McCord J, Newby K, Roe M, Dadkhah S, Siler-Fisher A, Ross M
Crit Pathw Cardiol. 2013 Sep;12(3):116-120

Bypassing the Emergency Department and Time to Reperfusion in Patients With Prehospital ST-Segment Elevation: Findings From the Reperfusion in Acute Myocardial Infarction in Carolina Emergency Departments Project
Bagai A, Al-Khalidi HR, Muñoz D, Monk L, Roettig ML, Corbett CC, Garvey JL, Wilson BH, Granger CB, Jollis JG
Circ Cardiovasc Interv. 2013 Jul 16. [Epub ahead of print]

ED administration of thienopyridines in non–ST-segment elevation myocardial infarction: results from the NCDR
Diercks DB, Kontos MC, Hollander JE, Mumma BE, Holmes DN, Wiviott S, Saucedo JF, de Lemos JA.
Am J Emerg Med. 2013 Jul;31(7):1005-11. doi: 10.1016/j.ajem.2013.03.001. Epub 2013 May 20

Operational data integrity during electronic health record implementation in the ED
Ward MJ, Froehle CM, Hart KW, Lindsell CJ.
Am J Emerg Med. 2013 Jul;31(7):1029-33. doi: 10.1016/j.ajem.2013.03.027. Epub 2013 May 23

Initial Management of Patients with Acute Heart Failure
Fermann GJ, Collins SP
Heart Fail Clin. 2013 Jul;9(3):291-301. doi: 10.1016/j.hfc.2013.04.004. Epub 2013 Jun 4.

Evaluation and Management of the Atrial Fibrillation Patient: A Report From the Society of Cardiovascular Patient Care
Steinberg BA, Beckley PD, Deering TF, Clark CL, Amin AN, Bauer KA, Cryer B, Mansour M, Scheiman JM, Zenati MA, Newby LK, Peacock WF, Bhatt DL; for the Society of Cardiovascular Patient Care
Crit Pathw Cardiol. 2013 Sep;12(3):107-115


View our member publication archive . . .




Legal information

EMCREG™ - International Department of Emergency Medicine

231 Albert Sabin Way
MSB Suite 1358F
Cincinnati, Ohio 45267-0769

Fell free to contact us at support@emcreg.org
or toll-free at 1-855-678-5061



Advanced Search

©Copyright EMCREG-International™ 2014. All rights reserved